TL;DR
This paper introduces a modified maximum contrast method for pharmacogenomic studies that improves detection power and reduces false positives, especially with unequal sample sizes, by eliminating dependence on nuisance parameters.
Contribution
The paper proposes a new modified maximum contrast method that is faster, more accurate, and less dependent on nuisance parameters compared to existing approaches.
Findings
The modified maximum contrast method has the lowest false-positive rate.
It is faster and more accurate than the permuted version.
Simulation studies confirm its effectiveness in various conditions.
Abstract
In pharmacogenomic studies, biomedical researchers commonly analyze the association between genotype and biological response by using the Kruskal--Wallis test or one-way analysis of variance (ANOVA) after logarithmic transformation of the obtained data. However, because these methods detect unexpected biological response patterns, the power for detecting the expected pattern is reduced. Previously, we proposed a combination of the maximum contrast method and the permuted modified maximum contrast method for unequal sample sizes in pharmacogenomic studies. However, we noted that the distribution of the permuted modified maximum contrast statistic depends on a nuisance parameter , which is the population variance. In this paper, we propose a modified maximum contrast method with a statistic that does not depend on the nuisance parameter. Furthermore, we compare the performance…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Code & Models
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
